Immutep's playing field...., page-8

I hesitate to say this because I'm not a medical person, I don't think I'm far off

the mark but what I say might need some polishing.......

In efti/keytruda trials efti encourages the immune system to release monocytes

that keytruda previously couldn't reach for treatment...Monocytes are a type

of white blood cells.....This is the basis of our combo trials with merck and keytruda

and if it can be proven that efti has a broad success rate with allowing keytruda access 

to targeted cells it couldn't get at solo, guess what?...we're in the money.....